 | • レポートコード：QYR9ST03014 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のレミケードバイオシミラー市場について調査・分析し、以下の構成でお届け致します。レミケードバイオシミラーの種類別には、100mg/10ml、500mg/50mlに、用途別には、血液疾患、腫瘍疾患に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別レミケードバイオシミラー売上データ ・地域別レミケードバイオシミラー市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別レミケードバイオシミラー市場規模：100mg/10ml、500mg/50ml ・用途別レミケードバイオシミラー市場規模：血液疾患、腫瘍疾患 ・主要メーカーの企業情報：Synthon Pharmaceuticals、LG Life Sciences、Novartis (Sandoz)、Celltrion、Biocon、Hospira、Merck Serono (Merck Group)、Biogen idec Inc.、Genentech (Roche Group) ・レミケードバイオシミラーの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. The global Remicade Biosimilar market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Remicade Biosimilar market based on company, product type, end user and key regions.
This report studies the global market size of Remicade Biosimilar in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Remicade Biosimilar in these regions.
This research report categorizes the global Remicade Biosimilar market by top players/brands, region, type and end user. This report also studies the global Remicade Biosimilar market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Market size by Product
100mg/10ml
500mg/50ml
Market size by End User
Blood Disorders
Oncology Diseases
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Remicade Biosimilar market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Remicade Biosimilar market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Remicade Biosimilar companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Remicade Biosimilar submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Remicade Biosimilar are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Remicade Biosimilar market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Remicade Biosimilar Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Remicade Biosimilar Market Size Growth Rate by Product
1.4.2 100mg/10ml
1.4.3 500mg/50ml
1.5 Market by End User
1.5.1 Global Remicade Biosimilar Market Size Growth Rate by End User
1.5.2 Blood Disorders
1.5.3 Oncology Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Remicade Biosimilar Market Size
2.1.1 Global Remicade Biosimilar Revenue 2014-2025
2.1.2 Global Remicade Biosimilar Sales 2014-2025
2.2 Remicade Biosimilar Growth Rate by Regions
2.2.1 Global Remicade Biosimilar Sales by Regions
2.2.2 Global Remicade Biosimilar Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Remicade Biosimilar Sales by Manufacturers
3.1.1 Remicade Biosimilar Sales by Manufacturers
3.1.2 Remicade Biosimilar Sales Market Share by Manufacturers
3.1.3 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI)
3.2 Remicade Biosimilar Revenue by Manufacturers
3.2.1 Remicade Biosimilar Revenue by Manufacturers (2014-2019)
3.2.2 Remicade Biosimilar Revenue Share by Manufacturers (2014-2019)
3.3 Remicade Biosimilar Price by Manufacturers
3.4 Remicade Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Remicade Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Remicade Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Remicade Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Remicade Biosimilar Sales by Product
4.2 Global Remicade Biosimilar Revenue by Product
4.3 Remicade Biosimilar Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Remicade Biosimilar Breakdown Data by End User
6 North America
6.1 North America Remicade Biosimilar by Countries
6.1.1 North America Remicade Biosimilar Sales by Countries
6.1.2 North America Remicade Biosimilar Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Remicade Biosimilar by Product
6.3 North America Remicade Biosimilar by End User
7 Europe
7.1 Europe Remicade Biosimilar by Countries
7.1.1 Europe Remicade Biosimilar Sales by Countries
7.1.2 Europe Remicade Biosimilar Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Remicade Biosimilar by Product
7.3 Europe Remicade Biosimilar by End User
8 Asia Pacific
8.1 Asia Pacific Remicade Biosimilar by Countries
8.1.1 Asia Pacific Remicade Biosimilar Sales by Countries
8.1.2 Asia Pacific Remicade Biosimilar Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Remicade Biosimilar by Product
8.3 Asia Pacific Remicade Biosimilar by End User
9 Central & South America
9.1 Central & South America Remicade Biosimilar by Countries
9.1.1 Central & South America Remicade Biosimilar Sales by Countries
9.1.2 Central & South America Remicade Biosimilar Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Remicade Biosimilar by Product
9.3 Central & South America Remicade Biosimilar by End User
10 Middle East and Africa
10.1 Middle East and Africa Remicade Biosimilar by Countries
10.1.1 Middle East and Africa Remicade Biosimilar Sales by Countries
10.1.2 Middle East and Africa Remicade Biosimilar Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Remicade Biosimilar by Product
10.3 Middle East and Africa Remicade Biosimilar by End User
11 Company Profiles
11.1 Synthon Pharmaceuticals
11.1.1 Synthon Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
11.1.5 Synthon Pharmaceuticals Recent Development
11.2 LG Life Sciences
11.2.1 LG Life Sciences Company Details
11.2.2 Company Business Overview
11.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.2.4 LG Life Sciences Remicade Biosimilar Products Offered
11.2.5 LG Life Sciences Recent Development
11.3 Novartis (Sandoz)
11.3.1 Novartis (Sandoz) Company Details
11.3.2 Company Business Overview
11.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis (Sandoz) Remicade Biosimilar Products Offered
11.3.5 Novartis (Sandoz) Recent Development
11.4 Celltrion
11.4.1 Celltrion Company Details
11.4.2 Company Business Overview
11.4.3 Celltrion Remicade Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Celltrion Remicade Biosimilar Products Offered
11.4.5 Celltrion Recent Development
11.5 Biocon
11.5.1 Biocon Company Details
11.5.2 Company Business Overview
11.5.3 Biocon Remicade Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Biocon Remicade Biosimilar Products Offered
11.5.5 Biocon Recent Development
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Company Business Overview
11.6.3 Hospira Remicade Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Hospira Remicade Biosimilar Products Offered
11.6.5 Hospira Recent Development
11.7 Merck Serono (Merck Group)
11.7.1 Merck Serono (Merck Group) Company Details
11.7.2 Company Business Overview
11.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products Offered
11.7.5 Merck Serono (Merck Group) Recent Development
11.8 Biogen idec Inc.
11.8.1 Biogen idec Inc. Company Details
11.8.2 Company Business Overview
11.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Biogen idec Inc. Remicade Biosimilar Products Offered
11.8.5 Biogen idec Inc. Recent Development
11.9 Genentech (Roche Group)
11.9.1 Genentech (Roche Group) Company Details
11.9.2 Company Business Overview
11.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Genentech (Roche Group) Remicade Biosimilar Products Offered
11.9.5 Genentech (Roche Group) Recent Development
12 Future Forecast
12.1 Remicade Biosimilar Market Forecast by Regions
12.1.1 Global Remicade Biosimilar Sales Forecast by Regions 2019-2025
12.1.2 Global Remicade Biosimilar Revenue Forecast by Regions 2019-2025
12.2 Remicade Biosimilar Market Forecast by Product
12.2.1 Global Remicade Biosimilar Sales Forecast by Product 2019-2025
12.2.2 Global Remicade Biosimilar Revenue Forecast by Product 2019-2025
12.3 Remicade Biosimilar Market Forecast by End User
12.4 North America Remicade Biosimilar Forecast
12.5 Europe Remicade Biosimilar Forecast
12.6 Asia Pacific Remicade Biosimilar Forecast
12.7 Central & South America Remicade Biosimilar Forecast
12.8 Middle East and Africa Remicade Biosimilar Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Remicade Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Remicade Biosimilar Product Picture
Table Remicade Biosimilar Market Segments
Table Key Manufacturers Remicade Biosimilar Covered
Table Global Remicade Biosimilar Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Remicade Biosimilar Sales Market Share by Product 2014-2025
Figure 100mg/10ml Product Picture
Table Major Manufacturers of 100mg/10ml
Figure 500mg/50ml Product Picture
Table Major Manufacturers of 500mg/50ml
Table Global Remicade Biosimilar Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Blood Disorders
Figure Oncology Diseases
Figure Remicade Biosimilar Report Years Considered
Figure Global Remicade Biosimilar Market Size 2014-2025 (Million US$)
Figure Global Remicade Biosimilar Sales 2014-2025 (K Units)
Table Global Remicade Biosimilar Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Remicade Biosimilar Sales by Regions 2014-2019 (K Units)
Table Global Remicade Biosimilar Sales Market Share by Regions 2014-2019
Figure Global Remicade Biosimilar Sales Market Share by Regions 2014-2019
Figure 2018 Global Remicade Biosimilar Sales Market Share by Regions
Table Global Remicade Biosimilar Revenue by Regions 2014-2019 (Million US$)
Table Global Remicade Biosimilar Revenue Market Share by Regions 2014-2019
Figure Global Remicade Biosimilar Revenue Market Share by Regions 2014-2019
Figure 2018 Global Remicade Biosimilar Revenue Market Share by Regions
Table Global Remicade Biosimilar Sales by Manufacturers (2014-2019) (K Units)
Table Global Remicade Biosimilar Sales Share by Manufacturers (2014-2019)
Figure Global Remicade Biosimilar Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Remicade Biosimilar Revenue by Manufacturers (2014-2019) (Million USD)
Table Remicade Biosimilar Revenue Share by Manufacturers (2014-2019)
Figure Remicade Biosimilar Value Share by Manufacturers in 2018
Table Key Manufacturers Remicade Biosimilar Price (2014-2019) (USD/Unit)
Table Remicade Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Remicade Biosimilar Product Type
Table Date of International Manufacturers Enter into Remicade Biosimilar Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Remicade Biosimilar Sales by Product (2014-2019) (K Units)
Table Global Remicade Biosimilar Sales Share by Product (2014-2019)
Figure Global Remicade Biosimilar Sales Market Share by Product (2014-2019)
Figure Global Remicade Biosimilar Sales Market Share by Product in 2018
Table Global Remicade Biosimilar Revenue by Product (2014-2019) (Million US$)
Table Global Remicade Biosimilar Revenue Share by Product (2014-2019)
Figure Global Remicade Biosimilar Revenue Market Share by Product (2014-2019)
Figure Global Remicade Biosimilar Revenue Market Share by Product in 2018
Table Remicade Biosimilar Price by Product 2014-2019 (USD/Unit)
Table Global Remicade Biosimilar Sales by End User (2014-2019) (K Units)
Table Global Remicade Biosimilar Sales Share by End User (2014-2019)
Figure Global Sales Remicade Biosimilar Market Share by End User (2014-2019)
Figure Global Sales Remicade Biosimilar Market Share by End User in 2018
Figure North America Remicade Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure North America Remicade Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table North America Remicade Biosimilar Sales by Countries (2014-2019) (K Units)
Table North America Remicade Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 North America Remicade Biosimilar Sales Market Share by Countries
Table North America Remicade Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table North America Remicade Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Remicade Biosimilar Revenue Market Share by Countries
Figure United States Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure United States Remicade Biosimilar Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Canada Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table North America Remicade Biosimilar Sales by Product (2014-2019) (K Units)
Table North America Remicade Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 North America Remicade Biosimilar Market Share by Product
Table North America Remicade Biosimilar Sales by End User (2014-2019) (K Units)
Table North America Remicade Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 North America Remicade Biosimilar Market Share by End User
Figure Europe Remicade Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure Europe Remicade Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Remicade Biosimilar Sales by Countries (2014-2019) (K Units)
Table Europe Remicade Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Remicade Biosimilar Sales Market Share by Countries
Table Europe Remicade Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table Europe Remicade Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Remicade Biosimilar Revenue Market Share by Countries
Figure Germany Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Germany Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure France Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure France Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure UK Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Italy Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Russia Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Remicade Biosimilar Sales by Product (2014-2019) (K Units)
Table Europe Remicade Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 Europe Remicade Biosimilar Market Share by Product
Table Europe Remicade Biosimilar Sales by End User (2014-2019) (K Units)
Table Europe Remicade Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 Europe Remicade Biosimilar Market Share by End User
Figure Asia Pacific Remicade Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Remicade Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Remicade Biosimilar Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Remicade Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Remicade Biosimilar Sales Market Share by Countries
Table Asia Pacific Remicade Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Remicade Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Remicade Biosimilar Revenue Market Share by Countries
Figure China Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure China Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Japan Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Korea Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure India Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure India Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Australia Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Remicade Biosimilar Sales by Product (2014-2019) (K Units)
Table Asia Pacific Remicade Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Remicade Biosimilar Market Share by Product
Table Asia Pacific Remicade Biosimilar Sales by End User (2014-2019) (K Units)
Table Asia Pacific Remicade Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Remicade Biosimilar Market Share by End User
Figure Central & South America Remicade Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Remicade Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Remicade Biosimilar Sales by Countries (2014-2019) (K Units)
Table Central & South America Remicade Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Remicade Biosimilar Sales Market Share by Countries
Table Central & South America Remicade Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Remicade Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Remicade Biosimilar Revenue Market Share by Countries
Figure Brazil Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Remicade Biosimilar Sales by Product (2014-2019) (K Units)
Table Central & South America Remicade Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Remicade Biosimilar Market Share by Product
Table Central & South America Remicade Biosimilar Sales by End User (2014-2019) (K Units)
Table Central & South America Remicade Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Remicade Biosimilar Market Share by End User
Figure Middle East and Africa Remicade Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Remicade Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Remicade Biosimilar Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Remicade Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Remicade Biosimilar Sales Market Share by Countries
Table Middle East and Africa Remicade Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Remicade Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Remicade Biosimilar Revenue Market Share by Countries
Figure GCC Countries Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Remicade Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Remicade Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Remicade Biosimilar Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Remicade Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Remicade Biosimilar Market Share by Product
Table Middle East and Africa Remicade Biosimilar Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Remicade Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Remicade Biosimilar Market Share by End User
Table Synthon Pharmaceuticals Company Details
Table Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Synthon Pharmaceuticals Recent Development
Table LG Life Sciences Company Details
Table LG Life Sciences Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table LG Life Sciences Recent Development
Table Novartis (Sandoz) Company Details
Table Novartis (Sandoz) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis (Sandoz) Recent Development
Table Celltrion Company Details
Table Celltrion Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Recent Development
Table Biocon Company Details
Table Biocon Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocon Recent Development
Table Hospira Company Details
Table Hospira Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hospira Recent Development
Table Merck Serono (Merck Group) Company Details
Table Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Serono (Merck Group) Recent Development
Table Biogen idec Inc. Company Details
Table Biogen idec Inc. Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen idec Inc. Recent Development
Table Genentech (Roche Group) Company Details
Table Genentech (Roche Group) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech (Roche Group) Recent Development
Table Global Remicade Biosimilar Sales Forecast by Regions 2019-2025 (K Units)
Table Global Remicade Biosimilar Sales Market Share Forecast by Regions 2019-2025
Table Global Remicade Biosimilar Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Remicade Biosimilar Revenue Market Share Forecast by Regions 2019-2025
Table Global Remicade Biosimilar Sales Forecast by Product 2019-2025 (K Units)
Table Global Remicade Biosimilar Sales Market Share Forecast by Product 2019-2025
Table Global Remicade Biosimilar Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Remicade Biosimilar Revenue Market Share Forecast by Product 2019-2025
Table Global Remicade Biosimilar Sales Forecast by End User 2019-2025 (K Units)
Table Global Remicade Biosimilar Sales Market Share Forecast by End User 2019-2025
Figure North America Remicade Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Remicade Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Remicade Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Remicade Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Remicade Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Remicade Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Remicade Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Remicade Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Remicade Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Remicade Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Remicade Biosimilar Value Chain
Table Remicade Biosimilar Customers List
Table Remicade Biosimilar Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
バイオシミラーの世界市場：インサイト・予測 A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference produ…- バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測 Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…
- バイオシミラー試験・開発サービスの世界市場：市場規模・現状・予測 The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified…
- 世界のハーセプチンバイオシミラー市場：専門的調査 Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vei…
- 世界のハーセプチンバイオシミラー市場：専門的調査 Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vei…